April 29 (Reuters) - Merck & Co Inc MRK.N:
MERCK BREAKS GROUND ON NEW $1 BILLION BIOLOGICS CENTER OF EXCELLENCE IN WILMINGTON, DELAWARE
MERCK BREAKS GROUND ON NEW $1 BILLION BIOLOGICS CENTER OF EXCELLENCE IN WILMINGTON, DELAWARE
MERCK & CO INC - NEW FACILITY TO CREATE 500 FULL-TIME ROLES AND 4,000 JOBS
MERCK & CO INC: MERCK WILMINGTON BIOTECH WILL SERVE AS A LAUNCH AND COMMERCIAL PRODUCTION FACILITY AND FUTURE U.S. HOME FOR KEYTRUDA
MERCK & CO INC - POTENTIAL EXPANSION COULD CREATE 1,500 FULL-TIME ROLES AND 26,000 JOBS
MERCK & CO: LABORATORY COMPONENT IS EXPECTED TO BE FULLY OPERATIONAL BY 2028, WITH PRODUCTION OF INVESTIGATIONAL COMPOUNDS TO START BY 2030
Source text: ID:nBw48V0nMa
Further company coverage: MRK.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.